Laser treatment for subfoveal neovascular membranes in ocular histoplasmosis syndrome: results of a pilot randomized clinical trial.

作者信息

Fine S L, Wood W J, Isernhagen R D, Singerman L J, Bressler N M, Folk J C, Kimura A E, Fish G E, Maguire M G, Alexander J

出版信息

Arch Ophthalmol. 1993 Jan;111(1):19-20. doi: 10.1001/archopht.1993.01090010021006.

DOI:10.1001/archopht.1993.01090010021006

PMID:7678731

Abstract

摘要

相似文献

Laser treatment for subfoveal neovascular membranes in ocular histoplasmosis syndrome: results of a pilot randomized clinical trial.

Arch Ophthalmol. 1993 Jan;111(1):19-20. doi: 10.1001/archopht.1993.01090010021006.

Surgical management of a long-standing subfoveal neovascular membrane secondary to ocular histoplasmosis.

Ophthalmic Surg. 1993 Jan;24(1):36-9.

New findings in ocular histoplasmosis.

Curr Opin Ophthalmol. 1995 Jun;6(3):8-12. doi: 10.1097/00055735-199506000-00002.

Bimanual technique of subfoveal neovascular membrane removal in presumed ocular histoplasmosis.

Int Ophthalmol. 1993 Feb;17(1):43-6. doi: 10.1007/BF00918867.

Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis.

Arch Ophthalmol. 1997 Aug;115(8):991-6. doi: 10.1001/archopht.1997.01100160161004.

Histopathologic examination of vascular patterns in subfoveal neovascular membranes.

Ophthalmology. 1994 Jun;101(6):1112-7. doi: 10.1016/s0161-6420(94)31228-0.

Managing recurrent neovascularization after subfoveal surgery in presumed ocular histoplasmosis syndrome.

Ophthalmology. 1996 Jul;103(7):1064-7;discussion 1067-8. doi: 10.1016/s0161-6420(96)30566-6.

Argon green vs krypton red laser photocoagulation for extrafoveal choroidal neovascularization. One-year results in ocular histoplasmosis. The Canadian Ophthalmology Study Group.

Arch Ophthalmol. 1994 Sep;112(9):1166-73.

The influence of treatment extent on the visual acuity of eyes treated with Krypton laser for juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.

Arch Ophthalmol. 1995 Feb;113(2):190-4. doi: 10.1001/archopht.1995.01100020074032.

The peril of the pilot study.

Arch Ophthalmol. 1996 Dec;114(12):1506-7. doi: 10.1001/archopht.1996.01100140704011.

引用本文的文献

LncRNAs in ocular neovascularizations.

Int J Ophthalmol. 2019 Dec 18;12(12):1959-1965. doi: 10.18240/ijo.2019.12.19. eCollection 2019.

Choroidal neovascularization secondary to tuberculosis: Presentation and management.

Am J Ophthalmol Case Rep. 2017 Jan 6;5:124-129. doi: 10.1016/j.ajoc.2016.12.025. eCollection 2017 Apr.

Choroidal neovascularization in 36 eyes of children and adolescents.

Eye (Lond). 2013 Oct;27(10):1158-68. doi: 10.1038/eye.2013.155. Epub 2013 Jul 26.

Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis.

Graefes Arch Clin Exp Ophthalmol. 2008 Dec;246(12):1685-92. doi: 10.1007/s00417-008-0906-4. Epub 2008 Aug 6.

Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression.

Br J Ophthalmol. 2005 Feb;89(2):147-50. doi: 10.1136/bjo.2004.046623.

Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: I. Ophthalmic findings from a randomized clinical trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9.

Arch Ophthalmol. 2004 Nov;122(11):1597-611. doi: 10.1001/archopht.122.11.1597.

Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases.

Graefes Arch Clin Exp Ophthalmol. 2003 Nov;241(11):899-906. doi: 10.1007/s00417-003-0734-5. Epub 2003 Oct 11.

Surgical removal of idiopathic, myopic and age-related subfoveal neovascularization.

Graefes Arch Clin Exp Ophthalmol. 1996 Aug;234 Suppl 1:S42-50. doi: 10.1007/BF02343047.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验